期刊文献+

松弛素在逆转心肌纤维化和主动脉硬化中的作用及其机制 被引量:5

下载PDF
导出
摘要 1 心肌纤维化和大血管硬化的临床意义 心肌纤维化是心脏疾患的基本病理变化之一,其严重程度和疾病的发生发展及预后密切相关[1]。此外,主动脉管壁纤维化也是多种原因所导致的心血管疾病的重要一环。例如在原发性高血压或高龄伴随的收缩性高血压中,大血管胶原纤维的含量增加所引起的血管性僵硬度增加即为其最重要的病理生理变化[2-4]。
出处 《中国医学前沿杂志(电子版)》 2011年第5期24-28,共5页 Chinese Journal of the Frontiers of Medical Science(Electronic Version)
基金 National Health and Medical Research Council funds(APP1004235 317808) Australian Research Council National Health and Medical Research Council of Australia National Heart Foundation of Australia
  • 相关文献

参考文献25

  • 1Berk BC;Fujiwara K;Lehoux S.ECM remodeling in hypertensive heart disease[J]Journal of Clinical Investigation,2007(03):568–575.
  • 2Greenwald SE.Ageing of the conduit arteries[J]Journal of Pathology,2007(02):157-172.
  • 3Avolio AP;Van Bortel LM;Boutouyrie P.Role of pulse pressure amplifi cation in arterial hypertension:experts' opinion and review of the data[J]Hypertension,2009(02):375-383.
  • 4Blacher J;Safar ME.Large-artery stiffness,hypertension and cardiovascular risk in older patients[J]Cardiovascular Medicine,2005(09):450-455.
  • 5Marque V;Grima M;Kieffer P.Withdrawal reveals lack of effect of prolonged antihypertensive treatment on intrinsic aortic wall stiffness in senescent spontaneously hypertensive rats[J]Clinical and Experimental Pharmacology and Physiology,2002(10):898-904.
  • 6Sherwood OD.Relaxin's physiological roles and other diverse actions[J]Endocrine Reviews,2004(02):205-234.
  • 7Bathgate RA;Ivell R;Sanborn BM.International Union of Pharmacology:Recommendations for the nomenclature of receptors for relaxin family peptides[J]Pharmacological Reviews,2006(01):7-31.
  • 8Du XJ;Bathgate RAD;Samuel CS.Cardiovascular effects of relaxin:from basic science to clinical therapy[J]Nature Reviews Cardiology,2010(01):48-58.
  • 9Dschietzig T;Bartsch C;Baumann G.RXFP1-inactive relaxin activates human glucocorticoid receptor:further investigations into the relaxin-GR pathway[J]Regulatory Peptides,2009(1-3):77-84.
  • 10Conrad KR.Maternal vasodilation in pregnancy:the emerging role of relaxin[J]American Journal of Physiology-Regulatory Integrative and Comparative Physiology,2011(02):R267-R275.

同被引文献98

  • 1杜晓军.松弛素治疗急性失代偿性心力衰竭临床研究的发现和转化启示[J].中国医学前沿杂志(电子版),2013,5(10):15-20. 被引量:3
  • 2《中国医学前沿杂志(电子版)》稿约[J].中国医学前沿杂志(电子版),2012,4(3):79-80. 被引量:1
  • 3Teerlink JR. Treatment of acutely decompensated heart failure[A].Wiley-Blackwell,UK,2010.327-356.
  • 4Felker GM,Pang PS,Adams KF. Clinical trials of pharmacological therapies in acute heart failure syndromes:lessons learned and directions forward[J].Circ Heart Fail,2010,(02):314-325.
  • 5Teerlink JR. Overview of randomized clinical trials in acute heart failure syndromes[J].American Journal of Cardiology,2005,(6A):59G-67G.
  • 6O'Connor CM,Starling RC,Hernandez AF. Effect of nesiritide in patients with acute decompensated heart failure[J].New England Journal of Medicine,2011,(01):32-43.
  • 7Du XJ,Bathgate RA,Samuel CS. Cardiovascular effects of relaxin:from basic science to clinical therapy[J].Nat Rev Cardiol,2010,(01):48-58.
  • 8Sherwood OD. Relaxin's physiological roles and other diverse actions[J].Endocrine Reviews,2004,(02):205-234.doi:10.1210/er.2003-0013.
  • 9Conrad KP. Maternal vasodilation in pregnancy:the emerging role of relaxin[J].American Journal of Physiology-Regulatory Integrative and Comparative Physiology,2011,(02):R267-R275.
  • 10Teerlink JR,Metra M,Felker GM. Relaxin for the treatment of patients with acute heart failure(Pre-RELAX-AHF):a multicentre,randomised,placebo-controlled,parallel-group,dose-ifnding phase IIb study[J].The Lancet,2009,(9673):1429-1439.doi:10.1016/S0140-6736(09)60622-X.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部